Key result
MSC exosome preconditioning enhances stem cell survival and restores cardiac function after myocardial infarction.
Answers are grounded in this paper and cite their sources.
BACKGROUND: Exosomes derived from mesenchymal stem cells (MSCs) were proved to boost cell proliferation and angiogenic potency. We explored whether cardiac stem cells (CSCs) preconditioned with MSC exosomes could survive and function better in a myocardial infarction model. METHODS AND RESULTS: DiI-labeled exosomes were internalized with CSCs. They stimulated proliferation, migration, and angiotube formation of CSCs in a dose-dependent manner. In a rat myocardial infarction model, MSC exosome-preconditioned CSCs had significantly better survival, enhanced capillary density, reduced cardiac fibrosis, and restored long-term cardiac function. MicroRNA profiling analysis revealed that a set of microRNAs were significantly changed in CSCs after MSC exosome treatment. CONCLUSIONS: Pretreatment of CSCs with MSC exosomes provided a promising strategy to improve survival and angiogenic potency of CSCs.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied Myocardial infarction. Cardiac stem cells preconditioned with MSC exosomes was evaluated on Cell survival, capillary density, cardiac fibrosis, and cardiac function. Preconditioning cardiac stem cells with MSC exosomes significantly improved their survival and angiogenic potency, and restored long-term cardiac function in a rat myocardial infarction model.
Synapse has enriched 10 related papers. Consider them for comparative context: